Anthropic quietly sets up biology lab as it ramps AI drug program: Report
The startup is expanding Claude Science and lab automation while restricting access to some models over biological dual-use risks, Reuters reported.
- Anthropic has established a wet lab in the San Francisco Bay Area to conduct physical biological experiments, expanding its artificial intelligence efforts into drug science, Eric Kauderer-Abrams confirmed on September 15.
- Seeking to treat rare conditions previously deemed "undruggable," Anthropic aims to accelerate life science progress, driven by Anthropic CEO Dario Amodei's personal mission after his father's death preceded a cure.
- Leveraging physical automation, Anthropic is using software like Claude Science to assist pharmaceutical firms including Roche and Novartis, while acquiring Coefficient Bio for approximately $400 million to bolster capabilities.
- While pushing into biology, Anthropic faces trust challenges as customers worry the company may access their competing drug data, despite data protection measures in place.
- The company prepares for a potentially $2 trillion IPO to fund AI development while navigating public skepticism over safety risks and potential biological weapons applications.
93 Articles
93 Articles
Anthropic Moves AI Into Physical Biology With Bay Area Lab
Anthropic has established an in-house biology laboratory in the San Francisco Bay Area as it expands Claude into life-science research, laboratory automation and preclinical drug ... The post Anthropic Moves AI Into Physical Biology With Bay Area Lab first appeared on [your]NEWS.
Anthropic has confirmed that it maintains a physical laboratory, where it tests drugs and real biological experiments, going far beyond computer simulation that so far characterized its work in life sciences. During...
Anthropic Builds Bay Area Wet Lab to Test AI's Real-World Biology Ambitions
Anthropic has opened a wet lab in the San Francisco Bay Area for physical biology experiments, confirmed by its head of life sciences. The facility supports Claude AI's push into protein design and automation while the company stresses human oversight and avoids clinical trials. Real-world validation now complements its digital advances.
Anthropic is operating a lab that conducts biology experiments
AI leaders have been promising that AI is the key to curing human disease. Anthropic researchers have also been warning that AI might kill us all.
Coverage Details
Bias Distribution
- 49% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium




















![[your]NEWS](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Ffb6dc495f74049f513563c33352175eaa0ecd509.jpg%3Fwidth%3D60&w=128&q=75)













